| Literature DB >> 25736994 |
Ying-Jie Dong1, Zi-Hui Meng1, Yan-Qing Mi1, Chun Zhang1, Zhi-Hao Cui1, Peng Wang1, Zhi-Bin Xu2.
Abstract
The worldwide threat from tuberculosis (TB) has resulted in great demand for new drugs, particularly those that can treat multidrug-resistant TB. We synthesized novel pleuromutilin derivatives with N-benzylamine side chain substituted at the C14 position and evaluated their activity in vitro against a virulent strain of Mycobacterium tuberculosis (H37Rv). The primary assay results showed that five compounds inhibited the H37Rv at 20μM, with a MIC of one of the analogues as low as 7.2μM.Entities:
Keywords: Antitubercular activity; N-Benzylamine side chain; Pleuromutilin derivatives
Mesh:
Substances:
Year: 2015 PMID: 25736994 DOI: 10.1016/j.bmcl.2015.02.023
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823